Comparing the treatment outcomes between unresectable and recurrent cases receiving gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer: Pooled analysis of two ...
Background: Patients with liver metastases (LM) from colorectal cancer (CRC) have a severe prognosis with the 5-year survival of 25% after radical resection; for not operable metastases the survival ...
AMSTERDAM, the Netherlands — For patients with unresectable intermediate-stage hepatocellular carcinoma, selective internal radioembolization and standard transarterial chemoembolization provide ...
Los Angeles, CA – September 3, 2025 - Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in ...
The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Treating liver cancer and liver metastases — cancer that has spread to the liver from elsewhere in the body — is challenging. Most patients are not candidates for surgery because there are many tumors ...
Treatment options for liver cancer vary based on the cancer stage and a person’s overall health and liver function. A person should work with their treatment team to determine the best treatment ...
Previous reports have also described the safety of resecting segments 7 and 8. However, they drew conclusions on smaller cohorts than our present study, and some included segments 1, 4a, 7, and 8, ...
News Medical on MSN
The mechanisms behind thrombocytopenia in patients with portal hypertension and chronic liver disease
Persistent liver injury halts the regenerative capacity of hepatocytes and activates mechanisms that result in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback